Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
Acadia Pharmaceuticals is seeking an Executive Director of Artificial Intelligence (AI) & Enablement to oversee the company's AI agenda, focusing on safety, ethics, value, and governance. The role will involve defining AI strategy, championing education, overseeing platform choices, and establishing governance frameworks for responsible AI adoption. The position is based in Princeton, New Jersey and requires 3 days per week in the office.
Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
Swayable